Blackstone Injects $125M into Drug Maker NantPharma
July 26, 2012
Blackstone (NYSE: BX) has announced a $125 million growth equity investment in pharmaceutical development and manufacturing company NantPharma. NantPharma currently operates numerous facilities across the country and recently purchased an additional plant in Terre Haute, Indiana previously owned by Pfizer that will receive $85.5 million in investment prior to opening in 2015. In addition to its investment, Blackstone procured three seats on NantPharma’s board.